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Summary
With technological advances in culture-independent
molecular methods, we are uncovering a new facet of
our natural history by accounting for the vast diversity
of microbial life which colonizes the human body. The
human microbiome contributes functional genes and
metabolites which affect human physiology and are,
therefore, considered an important factor for maintain-
ing health. Much has been described in the past
decade based primarily on 16S rRNA gene amplicon
sequencing regarding the diversity, structure, stability
and dynamics of human microbiota in their various
body habitats, most notably within the gastrointestinal
tract (GIT). Relatively high levels of variation have
been described across different stages of life and geo-
graphical locations for the GIT microbiome. These
observations may prove helpful for the future
contextualization of patterns in other body habitats
especially in relation to identifying generalizable
trends over human lifetime. Given the large degree of
complexity and variability, a key challenge will be how
to define baseline healthy microbiomes and how to
identify features which reflect deviations therefrom in
the future. In this context, metagenomics and func-
tional omics will likely play a central role as they will
allow resolution of microbiome-conferred functional-
ities associated with health. Such information will be
vital for formulating therapeutic interventions aimed at
managing microbiota-mediated health particularly in
the GITover the course of a human lifetime.
Introduction
Technological advances in culture-independent molecular
methods are allowing us to uncover a new facet of our nat-
ural history by accounting for the vast diversity of microbial
life, which colonizes the human body. Human beings are
now more than ever regarded as microbial ecosystems,
comprising bacteria, archaea, eukaryotes and viruses with
whom we have coevolved and which colonize different
body habitats. The human microbiome contributes essen-
tial functionalities to human physiology and is considered
essential for the maintenance of human health (Rooks
et al., 2014). As the microbiota in certain body habitats,
e.g. the gastrointestinal tract (GIT), are temporally stable
over the short- and medium-term (Voigt et al., 2015), the
definition of microbiome attributes associated with general
host characteristics, e.g. health, should be possible.
However, microbial community compositions vary over
human lifetimes and geographies (Yatsunenko et al.,
2012). Furthermore, relatively large intraindividual differen-
ces exist between distinct body sites and considerably less
but notable interindividual variation is apparent even
among healthy individuals for a given body site (Grice
et al., 2009; Franzosa et al., 2015; Voigt et al., 2015).
Consequently, it may be difficult to define site-specific
baseline microbiomes associated with human health espe-
cially at lower taxonomic ranks (such as at the genus,
species and/or strain levels). This restriction is in part due
to the limited resolution afforded by 16S rRNA gene ampli-
con sequencing which presently is the method of choice in
most studies. The structural differences which are typically
resolved at higher taxonomic ranks (such as at the phylum,
class and/or order levels) may not be very meaningful as
many distinct taxa are typically regrouped, thereby con-
founding linkages between specific microbial community
structures and health status. Therefore, future studies
encompassing metagenomics and functional omics will
allow much deeper insights into the structural and func-
tional complements of microbiota associated with health.
Nonetheless, individual body sites exhibit certain broad
features associated with health, that are resolvable using
16S rRNA gene-based surveys, which include specific dis-
tributions of microbial phyla, diversity and relative stability
over time (Fig. 1A).
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Fig. 1. Characteristics of the
‘healthy’ human microbiome.
A. The ‘healthy’ microbiome
of individual body sites
throughout human lifetime.
B. The ‘healthy’
gastrointestinal tract
microbiome across
geographies. Dots are
weighted according to the
overall abundance of distinct
phyla. Additional information
regarding the studies, based
on which Fig. 1 was devised,
are listed in Table S1.
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The human GIT microbiome has been the major focus of
studies as it contains the vast majority of microbial biomass
(Eckburg et al., 2005) and can relatively easily be sampled
by collection of fecal material. Additionally, it is intimately
involved in digestion, metabolite production, cross-talk with
the immune system (Flint et al., 2012), and has been impli-
cated in numerous disease processes (Kinross et al.,
2011). The human GIT microbiome is dominated by four
main bacterial phyla including Firmicutes, Bacteroidetes,
Actinobacteria and Proteobacteria (Ley et al., 2008). Given
their dominance, the Bacteroidetes and Firmicutes have
probably received the most attention with respect to the
microbial ecology of the GIT. While the Firmicutes are
primarily associated with energy harvest from food
(Turnbaugh et al., 2006), the Bacteroidetes are linked with
several health benefits due to their capacity to degrade
complex sugars and proteins into metabolizable short chain
fatty acids (SCFAs) (Ley et al., 2006).
Based on recent surveys, it is apparent that the human
GIT microbiome changes significantly over human lifetime
and that age-specific differences may be key to under-
standing microbiome-mediated effects on health. Although
other body habitats are distinct in their microbiota composi-
tions from the GIT, they remain much less explored with
regards to differences across age and geography. Conse-
quently, we use here the human GIT microbiome as a
template for discussing the development and changes of
the human microbiome over a lifetime while accounting for
biogeography, host genetics, diet and other environmental
influences. Although the microbial community composi-
tions in other body habitats, e.g. the skin, are shaped by
combinations of factors distinct from those in the GIT,
observations in the GIT microbiome with respect to coloni-
zation, succession and dynamics may prove helpful for the
future contextualization of patterns observed in other body
habitats in the context of human health. In particular, the
refinement of our understanding of normal variation within
microbial communities will further our knowledge of their
structure and function and allow us to identify key features
which reflect deviations therefrom, thereby facilitating the
design of advanced therapeutics aimed at managing
microbiota-mediated health over the course of life.
Development and succession of the GIT microbiome
over the human lifetime
In order to understand how the GIT microbiome is involved
in human health, we need to understand how the micro-
biome develops and evolves with age. The GIT
microbiome is dynamic over a human lifetime (Fig. 1A);
colonization may begin in utero, and the undifferentiated,
low diversity GIT microbiome at birth proceeds through
various developmental stages with associated changes
in diversity, structure and functional gene repertoires
(Yatsunenko et al., 2012; Hollister et al., 2015).
First exposures: in utero colonization
Until recently, it was assumed that the fetal environment is
sterile and that microbial colonization begins with birth.
However, with the advent of culture-independent molecular
methods, recent evidence has called this assumption into
question. The placenta, amniotic fluid, fetal membranes,
and cord blood from healthy, term pregnancies have been
shown to harbour microorganisms, suggesting that the
presence of bacteria in these tissues is not necessarily
indicative of a pathogenic state (Jimenez et al., 2005; Steel
et al., 2005; Rautava et al., 2012; Aagaard et al., 2014).
Furthermore, the application of culture-dependent and
culture-independent methods have demonstrated that
meconium is not sterile but contains bacterial communities
similar to those detected in amniotic fluid (Jimenez et al.,
2008a; Gosalbes et al., 2013; Ardissone et al., 2014).
Taken together, these results challenge the assumption of
a sterile in utero environment and suggest that initial colo-
nization of the GIT may begin before birth.
Potential sources of these pioneering microbes include
the vaginal microbiome (Aagaard et al., 2012; Romero
et al., 2014), resident bacteria in the uterus (Hemsell et al.,
1989; Cowling et al., 1992; Møller et al., 1995), and the
maternal digestive track including the oral cavity (Aagaard
et al., 2014). The vagina harbours an abundant, low diver-
sity microbiome dominated by Lactobacillus spp. and its
proximity to the fetus makes it a possible candidate for fetal
colonization (Aagaard et al., 2012). However, bacterial taxa
identified in the fetal environment are diverse and include
taxa associated with the oral and GIT microbiomes such as
Fusobacterium spp. and Bacteroides spp., suggesting the
vagina may not be the primary source of inoculum (Rau-
tava et al., 2012; Aagaard et al., 2014). Recent studies
have demonstrated that placentas from healthy, term preg-
nancies harbour a low abundance but diverse microbiome
most akin to the maternal oral microbiome, suggesting that
bacteria translocated from the oral cavity may colonize the
placenta and serve as an initial source for fetal exposure
(Aagaard et al. 2014; Zheng et al., 2015). Oral bacteria
may enter the blood stream via minor abrasions in the oral
mucosa (Lockhart et al., 2008), and preterm birth is associ-
ated with both periodontal disease and intrauterine
infection, suggesting hematogenous dissemination of bac-
teria from the oral cavity may be involved in both
physiological and pathological uterine bacterial colonization
(Goepfert et al., 2004; Klein and Gibbs, 2005; Schwendicke
et al., 2015). However, these routes of colonization remain
largely speculative, and further detailed studies are needed
to characterize the impact of the prenatal maternal micro-
biome on offspring colonization.
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Taking into account that development of the GIT micro-
biome may begin before birth, we must explore the factors
and exposures that influence this process. It is well
established that diet modulates the GIT microbiome in
adults (David et al., 2014), and recent studies have
revealed that maternal diet likely influences the offspring’s
microbiome as well. In a nonhuman primate study, a high
fat maternal diet (36% fat) during gestation and lactation
was associated with a persistent microbial dysbiosis in off-
spring even after they were weaned onto an isocaloric
control diet (13% fat) (Ma et al., 2014). While this study
failed to separate the effects of maternal diet during gesta-
tion and lactation, another study demonstrated that excess
gestational weight gain, but not obesity, is associated with
changes in the placental microbiome, suggesting maternal
diet during gestation may modulate colonization in utero
(Antony et al., 2015). In addition to maternal diet, antenatal
infection (Aagaard et al., 2014) and maternal stress during
pregnancy (Bailey et al., 2004) are associated with
changes in the placental microbiome. Moreover, pregesta-
tional diabetes (Hu et al., 2013) and prenatal probiotic
supplementation (Lahtinen et al., 2009) correlate with sig-
nificant changes in the offspring’s microbiome. Together,
this evidence suggests that the prenatal period plays a sig-
nificant role in shaping the offspring microbiome.
The microbiome at birth: perinatal influences
Compared to the adult microbiome, the GIT microbiome at
birth has significantly lower diversity and higher variability
among individuals (Fig. 1A) (Dominguez-Bello et al., 2010;
Yatsunenko et al., 2012). The dominant phyla in the
neonatal GIT include Firmicutes, Proteobacteria and Acti-
nobacteria with lower levels of Bacteroidetes, a dominant
phylum in the adult GIT microbiome (Fig. 1A) (Gosalbes
et al., 2013; Ardissone et al., 2014; Del Chierico et al.,
2015). Culture-based studies have reported a predomi-
nance of Bifidobacterium spp. (phylum Actinobacteria) in
the neonatal microbiome (Penders et al., 2006). These
taxa are known to elicit beneficial effects in their host by
breaking down dietary carbohydrates and interacting
directly with host metabolism (Davis et al., 2011). However,
many culture-independent studies have reported relatively
low abundances of Actinobacteria in the neonatal micro-
biome (Fig. 1A). This inconsistency may be explained by
poor PCR amplification of Bifidobacteria spp. due to varia-
tion in the conserved regions of the 16S rRNA gene. In
general, this circumstance highlights the need to consider
extraction and PCR bias when evaluating results from stud-
ies employing molecular methods (Milani et al., 2014).
Gestational age at delivery as well as mode of delivery
influence the neonatal microbiome at birth (Dominguez-
Bello et al., 2010; Ardissone et al., 2014). Compared to
infants delivered at term, the neonatal microbiome of pre-
term infants exhibits overall lower diversity and lower
abundance of Lactobacillus spp., Bacteroides spp. and
Bifidobacterium spp., with some differences persisting until
90 days postpartum (Arboleya et al., 2011, 2012, 2015). A
study of a large cohort of preterm infants demonstrated
that gestational age at birth appears to influence the pace,
but not necessarily the progression of bacterial coloniza-
tion, and that gestational age has a larger influence on the
progression of colonization compared to other exogenous
factors including antibiotic use, diet, and mode of delivery
(La Rosa et al., 2014). This association may be explained
by a microbiota-driven process involved in the pathogene-
sis of preterm birth, an altered neonatal environment of the
preterm infant or possibly an interruption in fetal coloniza-
tion in utero. While much has yet to be learnt about the
importance of these factors, recent evidence suggests that
the GIT microbiome of preterm infants is largely shaped by
microbiota derived from feeding and intubation as well as
the immediate incubator and room environment within neo-
natal intensive care units rather than by individuals who
come into contact with the infants (parents and healthcare
providers) (Brooks et al., 2014). Regardless of the main
factors at play, the microbial perturbations associated with
preterm birth are considered to be problematic for the
infant, as necrotizing enterocolitis, a severe inflammatory
disease of the GIT, is strongly associated with both pre-
term birth and microbial dysbiosis (Wang et al., 2009; Mai
et al., 2011).
In addition to gestational age, recent studies suggest
that mode of delivery may influence the immediate neona-
tal microbiome at birth, although the longer-term impact
remains unclear. In the immediate neonatal period, Cesar-
ean delivery is associated with an overall lower bacterial
diversity, a lower abundance of Bacteroides spp., Bifido-
bacterium spp. and Lactobacillus spp. and a bacterial
composition akin to maternal skin, while the meconium
microbiome of vaginally delivered infants is more similar to
the mother’s vaginal microbiome (Gr€onlund et al., 1999;
Penders et al., 2006; Biasucci et al., 2008, 2010;
Dominguez-Bello et al., 2010; Jakobsson et al., 2014).
However, many of these studies were limited in sample
size and failed to stratify subjects based on indication for
Cesarean delivery (e.g. unlabored repeat Cesarean versus
labored with fetal macrosomia). Thus, differences attrib-
uted to mode of delivery may be due to the underlying
pathology or fetal physiology that necessitates initial
Cesarean delivery. A recent study has found that, in an
attempt to recapitulate inoculation during passage through
the birth canal, exposure of Cesarean-delivered infants to
maternal vaginal fluids at birth results in a relatively mini-
mal effect on the bacterial community profile of anal swab
samples, reflecting the partial restoration of a few bacterial
taxa (Lactobacillus spp. and Bacteroides spp.) when com-
pared to levels found in samples from vaginally delivered
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infants (Dominguez-Bello et al., 2016). At present, it is diffi-
cult to definitively determine the significance of these
findings with respect to the GIT microbiome, as for exam-
ple the presence of these taxa may be due to direct
inoculation of vaginal bacteria to the perianal region during
the inoculation procedure rather than actual changes in
the GIT microbiome. Overall, further studies employing
larger sample sizes, longer sampling duration and stratifi-
cation by delivery indication are necessary to determine if
failure to pass through the birth canal has a significant,
lasting impact on infant microbial development.
The infant microbiome: development during the first year
of life
The first year of life represents a significant period of fluctu-
ation and maturation of the GIT microbiome (Fig. 1A).
Taxonomic diversity is relatively low at birth but increases
over time as the infant is colonized with bacteria acquired
from breast milk and the environment (Fig. 1A) (Schanche
et al., 2015; Thompson et al., 2015).
Diet is a significant driver of the developing infant micro-
biome as it adapts to the changing availability of nutrients
(Thompson et al., 2015). Early in infancy, the GIT micro-
biome is enriched in genes involved in digestion of
oligosaccharides found in breast milk, while later in infancy,
due to the introduction of solid foods, the metagenome is
enriched in genes involved in the digestion of polysaccha-
rides (contributed for example to the microbiome by
Bacteroides spp. (Ravcheev et al., 2013)) and vitamin bio-
synthesis (Koenig et al., 2011; B€ackhed et al., 2015).
Furthermore, the mode of feeding significantly influences
microbial composition in the infant GIT (Thompson et al.,
2015). Breast-fed infants show an increase in the relative
abundance of Actinobacteria and a decrease in Firmicutes
and Proteobacteria, while formula-fed infants exhibit
enrichments in putative pathogens, including Escherichia
coli and Clostridium difficile (Penders et al., 2006; Fallani
et al., 2010; Azad et al., 2013; Lee et al., 2015). Breast
milk contains multiple components that have the potential
to impact the composition of the infant GIT microbiome,
including immunoglobulins (Rogier et al., 2014), prebiotic
oligosaccharides (which favor the growth of Bifidobacte-
rium spp.) (Hardy et al., 2013), and diverse breast milk
microbiota that continually seed the infant GIT (Hunt et al.,
2011). Intriguingly, the breast milk microbiome includes
bacteria possibly derived from the maternal GIT via entero-
mammary trafficking, a proposed pathway by which enteric
bacteria are engulfed by leukocytes and delivered to the
mammary glands via systemic circulation (Stagg et al.,
2003; Perez et al., 2007; LaTuga et al., 2014). In support
of this potential pathway are results showing that oral pro-
biotics given to lactating mothers are detectable in breast
milk and identical bacterial strains are shared between the
maternal GIT, breast milk and the infant GIT (Jimenez
et al., 2008a,b; Jost et al., 2014). Thus, enteromammary
trafficking may represent a mechanism for vertical trans-
mission of the GIT microbiome. Given that diet significantly
affects the adult GIT microbiome (David et al., 2014), the
trafficking from maternal to infant GIT may explain the
observation that high fat maternal diet is associated with
persistent microbial dysbiosis in nursing offspring (Ma
et al., 2014). However, further studies are clearly needed
to elucidate the impact of the maternal GIT microbiota on
the developing microbiome of nursing infants.
In addition to infant diet, environmental and pharmaco-
logical exposures are also associated with differences in
the developing infant microbiome. These factors include
antibiotic exposure (Penders et al., 2006; Mangin et al.,
2010), number of siblings (Penders et al., 2006), exposure
to pets (Nermes et al., 2015), daycare attendance (Thomp-
son et al., 2015) and geography (Fallani et al., 2010).
Finally, the interindividual variation within the GIT micro-
biome is much larger in infants compared to adults
(Yatsunenko et al., 2012) suggesting that early succes-
sional patterns are not uniform, but nevertheless reach a
relatively similar endpoint in the adult microbiome (Yatsu-
nenko et al., 2012).
The GIT microbiome in childhood
Based on initial culture-based surveys, it was thought that
the human GIT microbiome reaches a mature state of colo-
nization between the ages of 1–4 years (Ellis-Pegler et al.,
1975). However, more recent molecular studies have
uncovered key differences in the GIT microbiome of chil-
dren and adults (Hopkins et al., 2001; Cheng et al., 2015;
Hollister et al., 2015). A study in the United States revealed
that compared to the adult GIT microbiome, there is an
overall clear enrichment in Firmicutes (Cheng et al., 2015;
Hollister et al., 2015), Proteobacteria (Saulnier et al., 2011)
and Actinobacteria (Cheng et al., 2015; Hollister et al.,
2015) and a decrease in Bacteroidetes (Saulnier et al.,
2011) in the GIT microbiome of American children.
Furthermore, Roseburia spp., Faecalibacterium spp., Rumi-
nococcus spp., Alistipes spp., Bacteroides vulgatus and
Bacteroides xylanisolvens were all found to be enriched in
preadolescent American children when compared to adult
counterparts (Hollister et al., 2015). Roseburia spp., Faeca-
libacterium spp. and Ruminococcus spp. are butyrate-
producing bacteria which are associated with a healthy GIT
microbiome (Khan et al., 2012; Neyrink et al., 2012; Zhang
et al., 2015). On a functional level, the GIT microbiomes of
children in the United States are enriched in functions which
may support ongoing development, e.g. vitamin B12 (Hollis-
ter et al., 2015) when compared to American adults. The
functional repertoires appear to shift over time and culmi-
nate in the adult GIT microbiome. Moreover, as we age the
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GIT microbiome is enriched in more traits associated with
inflammation and metabolic dysfunction (Hollister et al.,
2015).
As with other stages of life, there also appear to be clear
geographical differences with respect to the childhood
microbiome. In particular, the GIT microbiome of Italian
children is mainly comprised of Firmicutes, Bacteroidetes
and a smaller proportion of Actinobacteria (Fig. 1B). In
contrast, children residing in rural villages in Burkina Faso
exhibit a significant enrichment of Bacteroidetes and
depletion of Firmicutes and an enrichment in bacterial
genes capable of degrading cellulose and xylan (De Filippo
et al., 2010). To date, the functional characteristics of the
microbiome of children in all other geographical regions
remain to be explored in detail. Overall, the GIT micro-
biome in childhood, while more established than the infant
microbiome, is not completely mature and, therefore, rep-
resents a dynamic community which likely influences
health outcomes later on in life.
The GIT microbiome in adolescence
SimiIar to the child microbiome, it was assumed that the
microbiomes of adolescents are no different than those of
adults. However, a single molecular study has identified
differences in the adolescent GIT microbiome, including a
higher abundance of Clostridium spp. and Bifidobacteria
spp. compared to the adult microbiome (Hopkins et al.,
2001). Research on the healthy GIT microbiome in adoles-
cence barely exists and future studies are clearly needed
in this area. In particular, as fluctuating hormone levels are
a hallmark of adolescence, changes in the GIT microbiome
likely also occur during this important transitional period
similar to other life events associated with major hormonal
changes, e.g. pregnancy (Koren et al., 2012).
The GIT microbiome in adulthood
The majority of microbiome studies to date have focused
on the adult GIT microbiome, which comprises mainly Fir-
micutes, Bacteroidetes and Proteobacteria (Fig. 1B)
(Huttenhower et al., 2012). The proportion of each phylum
varies according to geographical location (Schnorr et al.,
2014). For example, a few studies have shown that Firmi-
cutes are enriched in adults in nonindustrialized countries
(Schnorr et al., 2014; Martinez et al., 2015), whereas
adults in westernized societies appear to exhibit a higher
Bacteroidetes to Firmicutes ratio (Huttenhower et al.,
2012; Zhu et al., 2015). However, this trend is not reflected
in two separate studies in which enrichments in Firmicutes
were observed for GIT microbiomes from European coun-
tries (Mueller et al., 2006; Arumugam et al., 2011). A
higher ratio of Firmicutes to Bacteroidetes has been mostly
attributed to energy harvest and body weight gain
(Turnbaugh et al., 2006). Additional future work is required
to clarify the relative levels of Firmicutes and Bacteroidetes
and their associated functionalities in healthy human popu-
lations across different geographies and their potential
impact on health and obesity.
Overall the adult GIT microbiome remains relatively sta-
ble through adulthood, except following perturbations such
as infections, antibiotic treatment or drastic dietary interven-
tions (David et al., 2014). Even though the GIT microbiome
recovers to its initial state relatively quickly (Wu et al., 2011;
David et al., 2014), these perturbations subtly alter the GIT
microbiome composition over time and are likely strong
drivers behind the extensive strain-level interindividual dif-
ferences which are apparent in healthy adults (Zhu et al.,
2015). Taken together, this suggests that the human holo-
genome [the collective of human and microbial genomes
(Moran and Sloan, 2015)] is very much individual-specific.
The GIT microbiome in old age
Studies from Europe suggest that the GIT microbiome in
the elderly is distinct from adults (Fig. 1B) (Mariat et al.,
2009). The GIT microbiome is thought to influence the
overall health of the elderly, as changes in its composition
have been associated with declines in health (Claesson
et al., 2012). Overall, the GIT microbiome of the elderly
exhibits a higher Firmicutes to Bacteroidetes ratio when
compared to adults (Mariat et al., 2009) with a concomitant
reduction in protective commensal bacteria such as Bifido-
bacteria and Bacteroides (Mariat et al., 2009). A reduction
in Bacteroides spp., Prevotella spp. and Faecalibacterium
prausnitzii (Mariat et al., 2009; Cho and Blaser, 2012), and
an increase in Enterobacteriaceae, has been associated
with on overall decrease in the quality of life in old age
(Van Tongeren et al., 2005). Factors which play a greater
role in old age and which might lead to the observed
changes in GIT microbiota include an overall increased
use of medication, dietary deficiency, as well as changing
hormonal levels (Voreades et al., 2014). In order to study
the dynamics of the healthy microbiome as we age, further
in-depth studies, including a focus on the identification of
specific microbiome-conferred functionalities in different
geographical regions are necessary. Furthermore, as
impaired dentition accompanies old age, it may be worth-
while to explicitly investigate the oral microbiome as this is
likely a contributor to changes in GIT microbiota (Claesson
et al., 2012) and consequently health status.
Age-independent influences on the GIT microbiome
and its modulation
Apart from age-associated changes in the GIT microbiota
of healthy individuals, other factors including geographical
location, social context, gender, host genetics, diet and
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antibiotic use may also greatly impact the composition of
the GIT microbiome (Fig. 2) (Dethlefsen et al., 2008;
Walker et al., 2011). In particular, apparent geographical
differences, for example between rural and urban areas
(Tyakht et al., 2013), may be attributable to variations in
dietary habits or other environmental influences (Fig. 2)
(De Filippo et al., 2010; Rampelli et al., 2015; Nakayama
et al., 2015). Apart from these factors, the differences
observed between school children attending private
schools compared to children living in impoverished condi-
tions may be the result of several social factors which are
presently difficult to deconvolute (De Mello et al., 2009).
These factors likely also contribute to the described associ-
ation between taxonomic structures and level of education
(Ding and Schloss, 2014). Furthermore, elderly individuals
that live in a community setting have higher proportions of
Firmicutes to Bacteroidetes in comparison to long-stay res-
idential individuals (Fig. 2) (Claesson et al., 2012). Data
from the Home Microbiome Project has found that the
human microbiome fingerprint is very similar between indi-
viduals that share the same home (Lax et al., 2014) which
in turn suggests an overall high degree of nestedness for
the GIT microbiome which likely further reinforces social
effects. These results as well as those from other studies
(Yatsunenko et al., 2012) suggest that the overall environ-
mental setting is a strong factor in shaping the human GIT
microbiome and, in more general terms, the microbiomes
of other body habitats.
Apart from environmental factors, host genetics have
also been found to shape GIT microbiome composition
(Goodrich et al., 2014; Blekhman et al., 2015). More spe-
cifically, many microbial taxa whose abundances appear to
be affected by host genetics have been identified (Good-
rich et al., 2014). Interestingly, the most heritable taxon
identified, the family Christensenellaceae, was found to be
enriched in individuals with low body mass index. When
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transplanted into germ-free mice, a Christensenellaceae
amendment reduced weight gain significantly and overall
altered the microbiome of recipient mice (Goodrich et al.,
2014). Strikingly, the heritability of Christensenellaceae did
not appear to be driven by diet and was, therefore, mainly
due to host genetic factors (Goodrich et al., 2014). Further-
more, gender-specific differences in GIT microbiome
composition have been observed, which may be explained
by combinations of host genetics and social context (Mar-
kle et al., 2013; Ding and Schloss, 2014).
Although diet appears not to be the main driver influenc-
ing microbiome composition, certain major taxa, e.g. the
Bacteroidetes, have been found to respond very rapidly to
dietary changes (David et al., 2014). In particular, Western
dietary habits have been found to significantly affect the
GIT microbiome which in turn has been linked to metabolic
diseases (Fukuda and Ohno, 2014; Hur and Lee, 2015).
The Western diet consists largely of processed foods and
is high in simple carbohydrates, animal protein, fat and low
in dietary fibre (De Filippo et al., 2010). In contrast, high
fibre diets are typically composed of fresh vegetables,
fruits and whole grains (Fung et al., 2001). Fibre-rich diets
can have short term-impacts on the GIT microbiome
(David et al., 2014), but more importantly long-term fibre
intake has been linked to microbiome-mediated beneficial,
systemic effects (Kuo, 2013). Interesting in this context are
Prevotella spp. and Xylanibacter spp., two genera capable
of degrading nondigestible fibres, which are enriched in
children from Burkina Faso and completely absent in Euro-
pean children (De Filippo et al., 2010). Fibre-degrading
bacteria ferment dietary fibre to SCFAs (Flint et al., 2012),
which provide an important source of energy for host cells
(B€ackhed et al., 2004; Turnbaugh et al., 2006) as well as
being involved in the maintenance of the epithelial barrier
(Kelly et al., 2015) and modulation of the immune system
(Furusawa et al., 2013). The two latter processes are par-
ticularly pertinent in the context of allergic diseases, which
show an increasing incidence world-wide, particularly in
Western countries (Azad et al., 2013). More specifically,
increased circulating levels of fibre-derived SCFAs have
been found to protect against inflammation in the lung of a
mouse model, whereas a low-fibre diet decreased levels of
SCFAs and increased allergic airway disease (Trompette
et al., 2014). Additionally, even though the results are not
conclusive, it seems that there is potential that the co-
administration of nondigestible fibre during antibiotic treat-
ment has promising effects on the GIT microbiome such
as prevention or alleviation of antibiotic-associated diar-
rhea (Moore et al., 2015).
Epidemiological data suggests that the increasing preva-
lence of antibiotic usage and general cleanliness in
Western countries (‘the hygiene hypothesis’) negatively
affects the GIT microbiome and that these contribute to
the increasing incidence in allergic diseases in these coun-
tries (Azad et al., 2013). The administration of antibiotics
directly perturbs the GIT microbiome leading to decreased
bacterial diversity and richness (Dethlefsen et al., 2008;
Claesson et al., 2011). Even though the GIT microbiome is
restored after approximately one month (Claesson et al.,
2011), some taxa are permanently lost (Dethlefsen et al.,
2008). However, these and other studies (Penders
et al., 2006; Mangin et al., 2010) have only investigated
microbial diversity before and after interventions and have
not examined transient and subsequent microbial meta-
bolic profiles nor the molecular repercussions over longer
durations. Even though antibiotic exposure might only
have relatively short-term effects on the microbiota, it might
activate long-term changes in gene expression that could
affect the immune system or metabolism which in turn might
culminate in chronic diseases (Nobel et al., 2015). Further-
more, facultative pathogens may occupy larger niches
postadministration which may lead to sustained pro-
inflammatory states (Gagliani et al., 2014). Clearly, detailed
longitudinal studies aimed at understanding the long-term
impact of antibiotic treatment on microbiome-mediated
health are needed to fully understand the resilience of the
GIT microbiome in relation to antibiotic exposure and to
identify possible supportive treatment strategies.
A well-established instance where persistent antibiotic
use leads to a major disruption of the GIT microbiota bal-
ance with potentially life-threatening consequences is that
of recurrent Clostridium difficile infection, which is particu-
larly prevalent in elderly individuals. In terms of treatment,
fecal microbiota transplantation (FMT) has recently proven
to be very efficacious as it results in the reestablishment of
a more diverse, ‘healthy’ microbiome (Kelly et al., 2014;
Dutta et al., 2014; Cohen et al., 2015). Apart from FMT,
other more classical means for modulating the GIT micro-
biome include the administration of defined pre-, pro- or
syn-biotic formulations (Hardy et al., 2013). Prebiotics
comprise nondigestible food components that promote the
growth of certain beneficial bacteria, e.g. SCFA-producing
bacteria, in the GIT. Examples include dietary supplemen-
tation with nondigestible fibre which promotes the growth
of Actinobacteria (Gerritsen et al., 2011; Johnson and Ver-
salovic, 2012; Simeoni et al., 2015). Actinobacteria have
been shown to be associated with health benefits and to
protect against pathogens by modulating the host’s
immune responses (Ventura et al., 2007). Probiotics are
living bacteria that can provide health benefits to the host
when administered in adequate amounts (Rijkers et al.,
2011) as they may potentially restore a disturbed GIT
microbiome (Sullivan and Nord, 2002) and activate anti-
inflammatory pathways (Eloe-Fadrosh et al., 2015). Cer-
tain probiotic species produce SCFAs and may secrete
other molecules, which, inter alia, may stimulate the
growth of other beneficial bacteria (Eloe-Fadrosh et al.,
2015) and thereby prevent the expansion of pathogenic
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bacteria (Collado et al., 2007). Synbiotics, which involve a
combination of probiotics and prebiotics administered
together, have been shown to favourably modulate interac-
tions between the GIT microbiome and host, and thereby
confer overall health benefits (Druart et al., 2014). More
specifically, modulation of the microbiome by synbiotic
regimes has been demonstrated to be efficacious for the
protection against sensitization to food allergens (Stefka
et al., 2014), the reduction of inflammation in the GIT (Fur-
rie et al., 2005) and a corresponding reduction in colorectal
cancer risk (Ohashi et al., 2002; Rafter et al., 2007; Liu
et al., 2011). Beyond the use of undefined modulatory
regimes, i.e. FMT, targeted age-group specific synbiotic
regimes may be further developed (Ley et al., 2006; De Fil-
ippo et al., 2010) to prevent or/and treat imbalanced GIT
microbiota over the course of human life.
Attributes of baseline ‘healthy’ microbiomes
Even though the GIT microbiome in healthy individuals is
considered to be relatively stable (Manichanh et al., 2008;
Ding and Schloss, 2014), the identification of features char-
acteristic of a ‘healthy’ microbiome is a challenging task.
Indeed, desirable microbial community structures associ-
ated with human health may be different for different
individuals according to their age, environment, genetics,
diet, etc., and may be more dependent on microbial gene
carriage patterns than taxonomic composition (Huttenhower
et al., 2012; Zhu et al., 2015). In contrast, given the relative
stability of functions encoded in GIT metagenomes (Hutten-
hower et al., 2012), it is likely that a core of microbiome-
conferred functionalities exists. The characteristics of such
a ‘functional core’ should be explored and its specific attrib-
utes in relation to human health should be investigated.
Many studies have identified microbial community
structures associated with specific diseases and corre-
spondingly, it is tempting to associate ‘health’ with the
features identified in the healthy control cohorts of these
studies. However, assigning causality to features associ-
ated with health and disease is a difficult problem and
often requires use of model systems, which at present do
not accurately reflect human physiology (Fritz et al., 2013).
Additionally, careful consideration of exclusion criteria
should be taken before these features are considered to
be reflective of a ‘healthy’ microbiome, as many studies
may identify ‘healthy’ features which may be associated
with other factors not under investigation. For example,
many studies have identified a relatively low Firmicutes to
Bacteroidetes ratio to be associated with health, as ele-
vated ratios have been linked to metabolic diseases (Ley
et al., 2006; Mariat et al., 2009). However, due to consider-
able variation in the observed Bacteroidetes to Firmicutes
ratios in healthy subjects, which may in turn be due to sev-
eral factors (Ley et al., 2006; Mariat et al., 2009), this ratio
is likely not be a generalizable indicator of human health
(Hollister et al., 2015).
Large-scale studies of healthy individuals screened with
extensive exclusion criteria such as the Human Micro-
biome Project and MetaHIT, have allowed us to begin to
define what is characteristic of healthy individuals, and this
should form the framework for defining features of ‘healthy’
microbiomes in the future. In addition to identifying micro-
bial community structures associated with human health,
studies should also focus on identifying specific functional-
ities and the corresponding bacterial taxa that confer these
functions to the individual. For example, some Bacteroides
spp. are known to produce specific beneficial products
such as polysaccharide A (Johnson et al., 2015) and
SCFAs (Walker et al., 2005; Ley et al., 2006). Although
16S rRNA gene-based analyses have a role to play for the
ab initio characterization of community structures, future
studies should involve the systematic generation of meta-
genomic and functional omic [metatranscriptomic,
metaproteomic, (meta-)metabolomics] data for resolving
the functional complements of microbiomes. Ultimately,
the functionalities encoded and conferred by the micro-
biota are key to ensuring health. Finally, the establishment
of a repertoire of beneficial bacterial strains is necessary
as their administration as probiotics potentially in conjunc-
tion with prebiotic formulations represents one of the most
promising avenues of microbiome-related therapeutics.
Characterization efforts aimed at defining ‘healthy’ micro-
biota compositions must be expanded beyond the lower
GIT microbiome, and links between different body sites
must be systematically investigated. For example, the oral
cavity is a main gateway for microorganisms to enter and
interact with the human body and the community types of
the oral and lower GIT microbiomes are predictive of each
other (Ding and Schloss, 2014). Additionally, the oral micro-
biome has been associated with oral infectious diseases as
well as systemic diseases (Ley et al., 2006; Seymour et al.,
2007). Consequently, the oral microbiome might be a key
factor for understanding human health over a human life-
time. Furthermore, it is also likely that alterations to the
microbiota in other body habitat, e.g. the skin (Weyrich
et al., 2015), may trigger systemic effects not least via
immune system responses. Clearly, microbial communities
at different body sites are involved in different aspects of
human health, and the systematic characterization of many
body sites is therefore imperative for our overall understand-
ing of microbiota-mediated health in the future.
Concluding remarks and perspectives
Given the complexity and diversity of microbial community
structures in healthy individuals (Huttenhower et al., 2012),
it may be at present difficult to define attributes characteris-
tic of baseline ‘healthy’ microbiomes. In spite of the
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relatively conserved, characteristic features of body site-
specific microbiota (Kurokawa et al., 2007; Huttenhower
et al., 2012; Hollister et al., 2015), it remains unclear which
factors influence microbial community assembly and their
relative importance. Key factors which likely influence
microbiota compositions include age (Palmer et al., 2007;
Mariat et al., 2009; Koenig et al., 2011), geographical loca-
tion (Yatsunenko et al., 2012), host genetics (Gagliani
et al., 2014; Blekhman et al., 2015), social context (De
Mello et al., 2009; Koenig et al., 2011; Nakayama et al.,
2015), and diet (David et al., 2014) (Fig. 2). Therefore, in
order to understand how the microbiome plays a role in
maintaining human health, studies aimed at identifying
measures that sustain beneficial microbiome compositions
over the course of a human lifetime along with high-
resolution longitudinal data in different geographic locales
is essential. Such data would need to include information
on highlighted factors influencing microbiome composition
as well as provide a sampling from different body sites of
individuals of different ages, ethnicities, socio-economic
backgrounds and geographies. Furthermore, such efforts
should go beyond mere 16S rRNA gene-based taxonomic
surveys and include systematically generated metage-
nomic and functional omic data. Given the microbiome’s
contribution of key functionalities to host physiology, the
inclusion of functional information will likely greatly
enhance the linking of microbial contributions to overall
health status. Additionally, it is essential that all data is
stored in a web-accessible comprehensive database to
allow comparisons of body-site specific microbiome char-
acteristics across studies. Therefore, in our opinion, a
standardized, concerted international effort is needed to
resolve and define the healthy human microbiome.
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